Acute and Chronic Pain After One-stage Hybrid Arrhythmia Ablation Surgery

December 11, 2025 updated by: Universitair Ziekenhuis Brussel

Acute and Chronic Pain After One-stage Hybrid Arrhythmia Ablation Surgery: A Study on the Presence of Chronic Pain After Hybrid Ablation and Factors That May be Associated

After one-stage hybrid arrhythmia ablation surgery there are possible side effects like acute and chronic pain. There is a lot of research surrounding these pains but not specifically after one-stage hybrid arrhythmia ablation surgery. The investigators want to research factors that may be associated with the absence of chronic pain after hybrid ablation include ketamine, peroperative opioids, loco-regional blocks, neuraxial blocks, wound infiltration, postoperative patient-controlled analgesia. The presence of corticosteroids or NSAIDS, will also be evaluated. Furthermore, non-adaptable factors such as genetics complicate the onset of chronic post-operative pain. Taking existing knowledge in this field into account, incidence risk as well as acute pain duration and intensity and their effects on chronic pain will become the primary focus of this study.

The investigators will contact all patients who had a one-stage hybrid arrhythmia ablation surgery at UZ Brussels. Participants will be sent a questionnaire with a consent form in and a survey asking about their pain 3 months postop and their current pain management therapy.

Study Overview

Status

Terminated

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

43

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Brussels Capital
      • Jette, Brussels Capital, Belgium, 1090
        • UZ Brussel

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 18 years of age or older
  • he/she must understand and read the Dutch, French or English language
  • be able to digitally agree to participate in the study
  • had to have a one stage hybrid procedure at least three months ago
  • have an ASA score of I, II or III.

Exclusion Criteria:

  • Patients with previously known chronic pain syndromes, fibromyalgia, complex regional pain syndrome are excluded.
  • Subjects with previous known chronic conditions such as diabetes neuropathy, rheumatoid arthri-tis, … are also excluded.
  • Subject are excluded if they underwent a surgical treatment within the observed period.
  • Patients are excluded when under treatment with chemotherapy/radiotherapy
  • Pregnant patients are also excluded.
  • Patients with known psychological conditions such as depression are excluded.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Control group
Patients are asked to fill in an online questionnaire concerning their postoperative pain.
Other: Chronic pain
Patients are asked to fill in an online questionnaire concerning their postoperative pain.
Other: Acute pain
Patients are asked to fill in an online questionnaire concerning their postoperative pain.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of patients with acute pain after one stage hybrid ablation.
Time Frame: 3 months postop
How many patients have acute pain after surgery
3 months postop
Number of patients with chronic pain after one stage hybrid ablation.
Time Frame: 3 months postop
How many patients have acute pain after surgery
3 months postop

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intensity of immediate pain following one stage hybrid ablation
Time Frame: 3 days
How painful on a numeric pain scale rating of 0 to 10 is the immediate pain post operation? 10 being the worst pain ever felt and 0 being totally painfree.
3 days
Duration of immediate pain following one stage hybrid ablation
Time Frame: 3 days
How long does the immediate pain post operation last?
3 days
Intensity of acute and chronic pain after receiving an advance anesthesiologic pain block.
Time Frame: 3 months
How painful on a numeric pain scale rating of 0 to 10 is the acute or chronic pain post operation? 10 being the worst pain ever felt and 0 being totally pain free.
3 months
Intensity of acute and chronic pain after administration of ketamine.
Time Frame: 3 months
How painful on a numeric pain scale rating of 0 to 10 is the acute or chronic pain post operation? 10 being the worst pain ever felt and 0 being totally pain free.
3 months
Intensity of acute and chronic pain after treatment with opioids.
Time Frame: 3 months
How painful on a numeric pain scale rating of 0 to 10 is the acute or chronic pain post operation? 10 being the worst pain ever felt and 0 being totally pain free.
3 months
Intensity of acute and chronic pain after placing of a thorax drain post operatively.
Time Frame: 3 months
How painful on a numeric pain scale rating of 0 to 10 is the acute or chronic pain post operation? 10 being the worst pain ever felt and 0 being totally pain free.
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2023

Primary Completion (Actual)

June 1, 2025

Study Completion (Actual)

June 1, 2025

Study Registration Dates

First Submitted

December 22, 2021

First Submitted That Met QC Criteria

January 26, 2022

First Posted (Actual)

January 27, 2022

Study Record Updates

Last Update Posted (Estimated)

December 18, 2025

Last Update Submitted That Met QC Criteria

December 11, 2025

Last Verified

April 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Pain

Clinical Trials on Questionnaire

Subscribe